Table 1:  Baseline Characteristics by Agent Received of Symptomatic Women with no Obstructive CAD.

Characteristics

Adenosine (n=99)

Regadenoson (n=40)

p-value

Age

54 ± 11

53 ± 11

0.52

Body mass index

29 ± 8

32 ± 7

0.01

Weight (kg)

72 ± 16

81 ± 19

0.01

Ethnicity (% Caucasian)

78 (79%)

31 (78%)

1

Diabetes

8 (8%)

6 (15%)

0.23

Hypertension

37 (37%)

17 (43%)

0.57

Current/former smokers

43 (43%)

19 (49%)

0.70

Dyslipidemia

8 (8%)

6 (15%)

0.23

Menopausal

32 (32%)

11 (28%)

0.69

Hormone replacement therapy

41 (41%)

21 (53%)

0.26

Ace-Inhibitor

19 (20%)

4 (11%)

0.31

Angiotensin Receptor Blocker

6 (6%)

2 (5%)

1

Beta-blocker

24 (26%)

11 (28%)

0.83

Diuretic

16 (16%)

8 (21%)

0.62

Birth Control Pill

74 (76%)

31 (82%)

0.65

mean ± standard deviation, or n (%)